Henry Schein Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Henry Schein Inc in the third quarter 2026?
Henry Schein Inc achieved a return on average equity (ROE) of 11.29 % in its third quarter 2026, which is below Henry Schein Inc 's average return on equity, which stands at 15.07%.

ROE has advanced compared to 10.88% in the second quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 34 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1380, from total ROE ranking in the second quarter 2026 at 1561.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Equity Change	-5.12 %	-6.63 %	-0.89 %	-3.27 %	-
Y / Y Net Income Change	9.17 %	8.51 %	-0.88 %	7.29 %	10.1 %
Net Income (TTM) in Millions	436	426	418	419	412
Return On Equity (TTM)	11.29 %	10.88 %	10.5 %	10.5 %	10.24 %
HSIC's Total Ranking	# 1380	# 1561	# 1360	# 1396	# 1344
Equity (TTM) in Millions	3,817	3,817	3,919	3,899	4,023
Seq. Equity Change	0 %	-2.6 %	0.51 %	-3.08 %	-1.59 %
Seq. Net Income Change	16.67 %	-8.93 %	8.74 %	-5.5 %	15.96 %

Back to HSIC Management Effectiveness >> HSIC's 5 Years Annual ROE >> Compare HSIC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 35
Sector	# 128
Overall	# 1380

Return On Equity Statistics
High	Average	Low
20.94 %	15.07 %	7.59 %
(Jul 01 2017)		(Sep 28 2024)

HSIC Annual Return On Equity	(Dec 27 2025) 2025	(Dec 28 2024) 2024	(Dec 30 2023) 2023	(Dec 31 2022) 2022	(Dec 25 2021) 2021
Total Equity in Millions	3,899	4,031	4,289	4,095	4,063
Y / Y Equity Change	-3.27 %	-6.02 %	4.74 %	0.78 %	1.98 %
Net Income in Millions	419	398	436	566	661
Y / Y Net Income Change	5.28 %	-8.72 %	-22.97 %	-14.31 %	57.48 %
Return On Equity	10.75 %	9.87 %	10.17 %	13.82 %	16.26 %

Back to HSIC Management Effectiveness >> HSIC's 5 Years Annual ROE >> Compare HSIC ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 10.75 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HSIC's' Return on Equity at Yahoo Finance
HSIC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HSIC's Competitors
Subscribers only: Roe for Henry Schein Inc 's Suppliers
Subscribers only: Return On Equity for HSIC's Customers

Companies with similar Return On Equity at Sep 26 2026, within Healthcare Sector	ROE
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %
Vertex Pharmaceuticals Inc	20.08 %
Ge Healthcare Technologies Inc	20.04 %
Neurocrine Biosciences Inc	19.74 %
Ani Pharmaceuticals Inc	19.70 %
Johnson and Johnson	19.55 %
Beone Medicines Ltd	18.21 %
Pediatrix Medical Group Inc	17.28 %
Kiniksa Pharmaceuticals International Plc	17.27 %
Krystal Biotech Inc	17.02 %
Intuitive Surgical Inc	16.99 %
Ensign Group Inc	16.62 %
Lemaitre Vascular Inc	15.81 %

Date modified: 2026-11-05T14:32:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.